WFSBP 2019 Final Program

57 Thursday, 6 June 2019 / Scientific Program WFSBP 2019 THU PL-04 PLENARY SESSION 10:00–11:00 Ballroom B/C Stem Cells and their potential for drug discovery for psychiatric disorders Chair: Peter Falkai, Germany Co-Chair: Sophia Frangou, USA Speaker: Evan Snyder, USA D-04 DEBATE 11:30–13:00 Ballroom B/C Cannabis legalization: Does it make sense? Chair: Phil Tibbo, Canada Co-Chair: Wei-Yi Song, Canada Proponent: Michael Krausz, Canada Opponent: Deepak Cyril D´Souza, USA T59: SUICIDE: BASIC/CLINICAL S-29 SYMPOSIUM 11:30–13:00 East Meeting Room 13 Psychobiology of suicide in men across the lifespan Chair: Leo Sher, USA Co-Chair: Jussi Jokinen, Sweden 001 Psychobiology of suicidal behavior in men across the lifespan: An overview Leo Sher, USA 002 Dramatically shortened life expectancy after the first suicide attempt among young men: Possible expla- nations with focus on preventable causes and neurobio- logical underpinnings Jussi Jokinen, Sweden 003 A surge in suicide among males: A lesson from Taiwan Shih-Cheng Liao, Taiwan 004 Emotion regulation and dimensional mediators of male suicide Timothy Rice, USA T41: POST TRAUMATIC STRESS DISORDERS S-70 SYMPOSIUM 11:30–13:00 Ballroom A Targeting metabotropic glutamate (mGlu) receptors for stress-related disorders Chair: Andrzej Pilc, Poland Co-Chair: Shigeyuki Chaki, Japan 001 mGlu5 receptors as a target for Post-traumatic Stress Disorder (PTSD) Carrie Jones, USA 002 Targeting group-II mGlu receptors in stress related disorders: Which subtype, which ligands Ferdinando Nicoletti, Italy 003 Role of serotonergic system in the antidepressant effects of mGlu2/3 antagonists and ketamine Shigeyuki Chaki, Japan 004 Group III mGlu receptors as a target for antipsy- chotic and/or antidepressant drugs Andrzej Pilc, Poland T52: SCHIZOPHRENIA AND OTHER PSYCHOSIS: BASIC/CLINICAL S-71 SYMPOSIUM 11:30–13:00 East Meeting Room 8/15 First episode psychoses: Long-term outcome and comorbidities Chair: Peter Falkai, Germany Co-Chair: Eric Chen, People‘s Republic of China 001 Modeling variability and heterogeneity in neuro- imaging data in psychosis Sophia Frangou, USA 002 The neurobiological basis of the long-term out- come in psychoses Peter Falkai, Germany 003 Relapse prevention in FEP: What do we learn from a 10-year-follow up? Eric Chen, People‘s Republic of China 004 Risk factors for relapse of psychosis in a homeless or marginally housed cohort William Honer, Canada